Lim Jeong Uk, Kim Deog Kyeom, Lee Myung Goo, Hwang Yong-Il, Shin Kyeong-Cheol, In Kwang Ho, Lee Sang Yeub, Rhee Chin Kook, Yoo Kwang Ha, Yoon Hyoung Kyu
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Tuberc Respir Dis (Seoul). 2020 Dec;83(Supple 1):S34-S45. doi: 10.4046/trd.2020.0031. Epub 2020 Oct 13.
Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) is a condition characterized by the overlapping clinical features of asthma and COPD. To evaluate the appropriateness of different sets of ACO definition, we compared the clinical characteristics of the previously defined diagnostic criteria and the specialist opinion in this study.
Patients enrolled in the KOrea COpd Subgroup Study (KOCOSS) were evaluated. Based on the questionnaire data, the patients were categorized into the ACO and non-ACO COPD groups according to the four sets of the diagnostic criteria.
In total 1,475 patients evaluated: 202 of 1,475 (13.6%), 32 of 1,475 (2.2%), 178 of 1,113 (16.0%), and 305 of 1,250 (24.4%) were categorized as ACO according to the modified Spanish Society of Pneumonology and Thoracic Surgery (SEPAR), American Thoracic Society (ATS) Roundtable, Global Initiative for Asthma (GINA)/Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria, and the specialists diagnosis, respectively. The ACO group defined according to the GINA/GOLD criteria showed significantly higher St. George's Respiratory Questionnaire and COPD Assessment Test scores than the non-ACO COPD group. When the modified SEPAR definition was applied, the ACO group showed a significantly larger decrease in the forced expiratory volume in 1 second (FEV1, %). The ACO group defined by the ATS Roundtable showed significantly larger decrease in the forced vital capacity values compared to the non-ACO COPD group (-18.9% vs. -2.2%, p=0.007 and -412 mL vs. -17 mL, p=0.036). The ACO group diagnosed by the specialists showed a significantly larger decrease in the FEV1 (%) compared to the non-ACO group (-5.4% vs. -0.2%, p=0.003).
In this study, the prevalence and clinical characteristics of ACO varied depending on the diagnostic criteria applied. With the criteria which are relatively easy to use, defining ACO by the specialists diagnosis may be more practical in clinical applications.
哮喘-慢性阻塞性肺疾病(COPD)重叠综合征(ACO)是一种具有哮喘和COPD重叠临床特征的疾病。为评估不同ACO定义集的适用性,我们在本研究中比较了先前定义的诊断标准的临床特征和专家意见。
对纳入韩国COPD亚组研究(KOCOSS)的患者进行评估。根据问卷数据,按照四套诊断标准将患者分为ACO组和非ACO COPD组。
总共评估了1475例患者:根据改良的西班牙胸科和呼吸外科学会(SEPAR)、美国胸科学会(ATS)圆桌会议、全球哮喘防治创议(GINA)/慢性阻塞性肺疾病全球倡议(GOLD)标准以及专家诊断,分别有1475例中的202例(13.6%)、1475例中的32例(2.2%)、1113例中的178例(16.0%)以及1250例中的305例(24.4%)被归类为ACO。根据GINA/GOLD标准定义的ACO组的圣乔治呼吸问卷和COPD评估测试得分显著高于非ACO COPD组。应用改良的SEPAR定义时,ACO组的一秒用力呼气容积(FEV1,%)下降幅度显著更大。与非ACO COPD组相比,ATS圆桌会议定义的ACO组的用力肺活量值下降幅度显著更大(-18.9%对-2.2%,p = 0.007;-412 mL对-17 mL,p = 0.036)。专家诊断为ACO的组与非ACO组相比,FEV1(%)下降幅度显著更大(-5.4%对-0.2%,p = 0.003)。
在本研究中,ACO的患病率和临床特征因应用的诊断标准而异。对于相对易于使用的标准,在临床应用中由专家诊断来定义ACO可能更具实用性。